Dr. Behnam of Santa Monica, CA has been named a Patients' Choice Award Winner for 2012
Santa Monica, CA, December 12, 2012
Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Sean Behnam from Santa Monica California, a prominent Hair Transplant Specialist.
In fact, of the nation's 870,000 active physicians and dentists, just five percent consistently received top scores from their patients. Millions of patients go online each year to rate their doctors on various components of care, including accuracy of their diagnosis, the amount of time they spent with the doctor, and the doctor's bedside manner and follow-up care. Patients' Choice reviews these rankings and other quality measures to compile its yearly list of award winners.
Dr. Sean Behnam commented on this monumental recognition: "I'm so honored to receive an award that is based on patients’ view of the quality of care I have provided. I strive to exceed my patients’ expectations every day, and I’m grateful that my patients have recognized my efforts.”
This award signifies the continued commitment and dedication of Dr. Sean Behnam to the field of Hair Transplant Surgery and Hair Restoration. Dr. Sean Behnam is a prominent Hair Transplant Specialist practicing in Santa Monica California for the past 10 years. Dr. Behnam believes since the mind, body image, and spirit are inextricably connected, emotional wellness is the single most important factor that can dramatically impact all areas of a patient’s life. “To be able to grant my patients with a better self-esteem through Hair Transplant is a God Given Gift that I do not take for granted”, says Dr. Behnam.
Not only a gifted Physician, Dr. Sean Behnam is also a deep person that cares about his patients. He realizes that making a change to the outer person can make an even more valuable change to the inner person. Dr. Behnam does not take his aesthetic vision in people's lives lightly and strives to achieve the perfect outcome for every single patient.
Dr. Sean Behnam is Santa Monica Hair Transplant Surgeon offering cutting edge Hair Restoration surgery. He is known nationally and internationally for his innovative surgical methods, excellent artistic vision, and his gift to put his aesthetic vision into reality.
Dr. Sean is a fellow researcher, an innovator, a teacher, and an artistic leader. Over the past few years, he has modified significant steps in hair restoration surgery for its aesthetic value. He has also made the process easier for patients. His intense effort in modifying hair transplant practice has led to less downtime, minimal to no swelling after the procedure, minimal scabbing, no bruising, and better patient experience overall. Dr. Behnam’s patients who have had previous procedures elsewhere say that his care and attention to artistic details make the experience in his clinic a total joy. Dr. Behnam’s patients describe it as relaxing, rejuvenating, and an artistic transformation.
Dr. Behnam uses the most advanced tools for each procedure; the highest powered microscopes for harvesting grafts; smallest custom made instruments for creating recipient sites. Dr. Behnam is actively involved in researching new and better ways of hair restoration. Over the past few years, he has developed ways to minimize swelling after hair transplants, minimize scabbing, minimize pain, and increase graft survival. Dr. Sean Behnam is an Hair Transplant expert in the field of Follicular Unit Extraction or FUE. Follicular Unit Extraction or FUE procedure is an advanced hair transplant procedure where individual hair follicles or hair grafts are removed one at a time from back of the scalp and transplanted into the recipient areas. Dr. Behnam has performed a lot of FUE procedures, and his experience and expertise are crucial in achieving great results.
Dr. Behnam uses the “Trichophytic Closure Method” which is a special way of closing scalp tissue which results in minimal scarring. He also uses double layer closure technique, with interior dissolvable sutures and outer staples. He also has every patient perform at least 2 weeks of scalp exercise, which increases scalp elasticity. All these combined reduce scarring significantly.
Dr. Behnam artistically creates a hairline that frames the face and is undetectable. “Honesty is our integrity” says Dr. Behnam. Dr. Behnam does not do any procedure on anyone if he feels the patient will not have a great result.
Dr. Behnam completed his training at the top US medical schools and residency programs followed by an intense training in hair restoration at the Distefano Hair Restoration Centers. Dr. Sean Behnam attended Medical School at the Oregon Health Sciences University, University of California, San Francisco (UCSF-Fresno) for Residency, and concluded his Hair Transplant Training Fellowship in Distefano Hair Restoration Centers.
Many patients come to Santa Monica for Dr. Sean Behnam’s artistic hair transplant procedure from all over the world. Dr. Behnam has earned their trust by his impeccable reputation in the field of Hair Restoration surgery, and by having performed successful surgeries for them in the past.
Located in beautiful Santa Monica, Dr. Sean Behnam and his staff pride themselves on discretion and follow-up care. Their goal is to offer their patients the high-quality experience that the Santa Monica community has come to enjoy.
"My reputation as a board certified surgeon is built on attention to the details that bring the results you're looking for," said Dr. Sean Behnam. "Whether we can assist you with Hair Transplant or other non-surgical options, our foremost desire is helping you achieve your personal goals."
Following the publication of Sean Behnam's selection for the Patient's Choice Award, American Registry seconded the honor and added Dr. Behnam to The Registry™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor.
For more information on Dr. Sean Behnam, located in Santa Monica, CA, please call 310-315-4989.
Patients' Choice provides in-depth information on doctors in your area who have been recognized and awarded for outstanding patient care and expertise. The Patients' Choice Award is the honor roll of physicians who have received the highest ratings by their patients.
Please visit our website at Santa Monica Hair Transplant and Hair Restoration for all offered services.
Dr. Sean Behnam
Email Address: firstname.lastname@example.org
Dr. Sean Behnam Selected For "Patients' Choice Award 2012."
Source: American Registry and Patients' Choice on behalf of Dr. Sean Behnam
Ben Behnam, MD Spotlighted as a “Leader in Medical Dermatology” in Newsweek 2011 Leaders Series
Board-certified Dermatological physician spotlighted as a leader in Dermatology and Skin Cancer Detection and Prevention.
Santa Monica, California December 19, 2012
Board-certified Santa Monica Dermatology physician Ben Behnam, M.D., has been spotlighted as a leader in medical dermatology and appeared in the December 11, 2011 issue of Newsweek magazine.
Dr. Ben Behnam is the founder and medical director of Santa Monica Dermatology and Hair Restoration Specialist. With locations in Santa Monica and Cedars Sinai Hospital, these centers provide dermatological services such as skin cancer detection and prevention, skin cancer surgery, MOHS surgery, Melanoma detection and recovery, full skin check, Mole check, and treatments for acne, warts, eczema, rosacea, and hair loss. Dr. Behnam also performs fractional CO2 laser, TCA Cross, subcision, chemical peels, Fraxel, Restylane, Juvederm, Radiesse, and Sclerotherapy,
Dr. Behnam was selected by a research team from a search of qualified physicians in good standing with leading and accredited organizations practicing within the medical Dermatology. Dr. Behnam appeared in the December 11, 2011 issue of Newsweek. This feature spotlighted only “top physicians and surgeons” as identified by Newsweek.
An innovator, Dr. Ben Behnam MD, U.S. Leading Santa Monica Dermatologist, is a board certified dermatologist recognized nationally by Newsweek as one of the top 10 Physicians and Surgeons in the US, with appearances on The Doctors Show, FOX Good Day LA and ABC News. Dr. Behnam is committed to early detection and prevention of skin cancers and specializes in skin cancer screening, mole check and skin cancer removal, including Mohs Micrographic Surgery. He uses the most advance technology, the dermatoscope, for better evaluation and identification of moles. Dr. Behnam has been involved in clinical trials and has been widely published in journals such as the Journal of American Academy of Dermatology, Journal of Drugs in Dermatology, Cutis, Expert Opinion in Pharmacotherapy and others.
Dr. Behnam graduated Summa Cum Laude from UCLA. He attended UC Irvine School of Medicine, which he graduated top of his class with an AOA distinction. He did his dermatology training under the renowned and prominent cosmetic and Mohs surgeon Dr. Christopher Zachary at UC Irvine School of Medicine. He had the distinction of being the Chief Resident in his senior year. During residency, he was among few in the country to be awarded the Skin Disease Education Foundation Resident Award.
With his own proprietary chilling technology that allows pain free laser scar and wrinkle removal, Dr. Behnam is world renowned laser and skin cancer specialist. He is an expert in cosmetic procedures, contouring and sculpting the face with the combination use of Botox, Dysport, Juvederm, Restylane and Radiesse. He specializes in Laser resurfacing of the face.
Dr. Ben Behnam
Email Address: email@example.com
Patients With Psoriasis Suffering Feelings Of Isolation, Stigmatisation And Anxiety
Data from the Burden of Psoriasis patient research were presented this weekend at the 21st EADV Congress in Prague, Czech Republic. The results from the research, which included a quantitative online survey completed by 3,822 patients with psoriasis, showed 73% of patients surveyed scored their psoriasis as having a moderate to high impact on their lives1.
People living with psoriasis experience flare-ups that can result in the appearance of thick, red, scaly skin lesions on any part of their body2. The skin is often sore and itchy2, 3, but the current study emphasizes that the psychological impact of psoriasis can have an even greater impact on patients' everyday lives1.
Factors analysed in the research included the influence of symptom burden, healthcare professional (HCP) relationships, patient factors and the psychosocial impact of psoriasis on how much the patient's psoriasis "dictates how they live their life"1. Factors that were most strongly associated dealt with daily activities, stigmatisation, isolation and anxiety. However, diagnosed symptom severity was not a significant indicator1.
Commenting on the research Dr Anthony Bewley, Whipps Cross University Hospital & Barts & the London NHS Trust, UK, said, "The reality for patients is that the reactions of other people, real or perceived, can make life a real struggle. We need to ensure that we actively question our patients about these issues, and modify management accordingly. We plan further analysis of this comprehensive data set, which we believe will help to individualise care".
"The physical, psychological and social effects of psoriasis can have a serious impact on people's lives," said LEO Pharma President and CEO Gitte P. Aabo. "To give people with psoriasis the best chance of improving their quality of life, we need to address the issues that affect them individually. The Burden of Psoriasis patient research will help healthcare professionals learn more about the impact that psoriasis has on peoples' lives and hence inform and help evolve the way the disease is treated."
Scratching The Surface
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population.
A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zrich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 might be a useful therapeutic target in the treatment of psoriasis.
TITLE: Psoriasiform dermatitis is driven by interleukin-36-mediated dendritic cell-keratinocyte crosstalk
Psoriasis And Increased Risk For Diabetes
An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.
The findings appear in an article titled "Psoriasis and the risk of diabetes: a systematic review and meta-analysis," which is now online in theArchives of Dermatology.
"Our investigation found a clear association between psoriasis and diabetes," said April Armstrong, assistant professor of dermatology at UC Davis and principal investigator of the study. "Patients with psoriasis and their physicians need to be aware of the increased risk of developing diabetes so that patients can be screened regularly and benefit from early treatment."
Psoriasis is a common skin problem that tends to run in families. It causes a raised red, flaky and sometimes itchy rash, often on the elbows and knees, although it can appear anywhere. It is believed to be an autoimmune disease, in which the body regards its own skin as foreign and mounts an inflammatory response.
Armstrong and her colleagues combined data from 27 observational studies of patients with psoriasis, in what is known as a meta-analysis. Five of the studies assessed the incidence of diabetes - that is, how many patients with psoriasis developed diabetes during the course of a study, which ranged from 10 to 22 years. The other studies assessed the prevalence of diabetes - how many patients already had diabetes at the outset of a study. Altogether, the studies evaluated more than 314,000 people with psoriasis and compared them to 3.7 million individuals (controls) without the disease.
Some of the studies classified patients by disease severity. The aggregate data for these studies showed that patients with mild psoriasis are over 1.5 times more likely to have diabetes than the general population while those with severe disease are nearly twice as likely. Among studies that assessed incidence, patients with psoriasis had a 27 percent increased risk of developing diabetes compared with the general population.
All but one study analyzing incidence found a link between psoriasis and diabetes. These studies included patient data from outpatient clinics, insurance claims and hospitals. Diabetes rates were similar in patients despite ethnicity or country where the study was conducted.
"The large sample size and consistent association between psoriasis and diabetes make these study findings very strong and suggest an underlying physiological link between the two diseases," said Armstrong, who directs the Dermatology Clinical Research Unit at UC Davis and the teledermatology program.
While additional research is need to understand how the two diseases are associated, Armstrong believes altered immune pathways may make psoriasis patients more susceptible to developing diabetes.
"There is evidence that fat cells in psoriasis patients may not function normally," she said. "These cells secrete inflammatory substances known as cytokines that increase insulin resistance in the liver and muscle and initiate destruction of insulin-producing cells in the pancreas."
Additional research will also clarify other potential limiting factors in the current study. For example, the study's authors noted that epidemiological or observational studies can be susceptible to confounding factors, such as concurrent medications used to treat psoriasis that may modulate the risk of developing diabetes.
Armstrong's study adds to a growing body of research that shows psoriasis is not just skin deep. "We know patients with psoriasis and hypertension tend to require more aggressive therapy to bring their blood pressure under control," said Armstrong. "We also know that psoriasis patients have higher rates of heart attacks, strokes and cardiovascular-related deaths than the general population. Primary-care physicians need to be aware of these underlying predispositions to disease to provide the best care to their patients."
Armstrong and her colleagues plan to examine endothelial cells - cells that line blood vessels - to better understand the underlying physiological basis of psoriasis. They also are collaborating with other research institutions to develop a network to share clinical data on patients with psoriasis.
More than 15% of children suffer with eczema, or atopic dermatitis, an inflammatory skin disease that in some cases can be debilitating and disfiguring. Researchers reporting in the October issue of Immunity have discovered a potential new target for the condition, demonstrating that by blocking it, they can lessen the disease in mice.
In eczema, immune T cells invade the skin and secrete factors that drive an allergic response, making the skin itch. Dr. Raif Geha, of Boston Children's Hospital, and his collaborators now show that scratching the skin precipitates the condition by encouraging an influx of other immune cells called neutrophils. These neutrophils secrete a lipid called leukotriene B4 that calls in more neutrophils, and more importantly, potent immune T cells that are the hallmark of eczema. These cells cause inflammation that aggravates the skin further. The investigators suspected that blocking the onslaught of these cells might slow down the disease or even stop it in its tracks.
Furthermore, Dr. Geha and his colleagues wondered whether the production of leukotriene B4 served to recruit T cells to the site of mechanical insult. And indeed that was the case. "We showed that a drug that blocks the production of leukotriene B4 blocks the development of allergic skin inflammation in a mouse model of eczema," says Dr. Geha. His team also found that deleting the receptors on immune cells that bind to leukotriene B4 had a similar effect.
"Our findings suggest that neutrophils play a key role in allergic skin inflammation and that blockade of leukotriene B4 and its receptor might provide a new therapy for eczema," says first author Dr. Michiko Oyoshi.
Most people get eczema as infants, and they tend to outgrow it by adolescence; however some people continue to experience "flare-ups" of an itchy rash on and off throughout life. Some develop these after coming into contact with particular substances, such as specific soaps, or in response to certain conditions, such as a respiratory infection or cold.